(G064) INT2GRATE Oncology Consortium: A Novel Variant Evidence Framework for Cancer Syndromes and Data-Sharing Platform for Integrated Germline and Tumor Variants

Thursday, November 21, 2024

3:00 PM – 3:15 PM PST

Location: 109 & 110, Level 1

CE Credit: 1.0

Poster Presenter(s)

Arezou A. Ghazani, MSc, PhD, FACMG

Director of Clinical Genomics, Brigham Genomic Medicine
Brigham and Women’s Hospital, Harvard Medical School
Boston, Massachusetts, United States